| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 03/04/2004 | US20040044008 Dietetics; antilipemic agents; non-insulin dependent diabetes; cardiovascular disorders |
| 03/04/2004 | US20040044007 Pyschological and central nervous system diosrders; neurolptics; side effect reduction |
| 03/04/2004 | US20040043965 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents |
| 03/04/2004 | DE10239479A1 New pyrrole or furan derivative spiro-cyclic ketoenol compounds, useful as pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides, fungicides, herbicides or bactericides |
| 03/03/2004 | EP1394240A1 Bicyclic thioamides as additives for lubricating oils |
| 03/03/2004 | EP1394163A1 Bicycloamide derivatives |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1393747A1 Preventives/remedies for alzheimer's disease |
| 03/03/2004 | EP1392659A1 Methods of making indazoles |
| 03/03/2004 | EP1392658A1 Novel fused indazoles and indoles and their use for the treatment of glaucoma |
| 03/03/2004 | EP1392655A2 Potassium channel openers |
| 03/03/2004 | EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators |
| 03/03/2004 | EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives |
| 03/03/2004 | EP1392637A2 Modulators of peroxisome proliferator activated receptors |
| 03/03/2004 | EP1392289A2 Caspase inhibitors and uses thereof |
| 03/03/2004 | EP1124797B1 N-arylsulfonyl amino acid omega amides |
| 03/03/2004 | CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 03/03/2004 | CN1478770A 1,3-dicarbonyl compound and its preparation and use |
| 03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
| 03/03/2004 | CN1140510C Thermodynamically stable from of (R)-3[[(4-fluorophenyl)sulphonyl]amino]- 1,2,3,4-tetraydro-9H-carbazole-9-propanoic acid (ramatroban) |
| 03/03/2004 | CN1140508C Substed 4-biphenyl-4-hydroxybutyric acid derivs, and matrix metalloprotease inhibitors |
| 03/03/2004 | CA2438909A1 1,4-substituted cyclohexane derivatives |
| 03/03/2004 | CA2400996A1 1,4-substituted cyclohexane derivatives |
| 03/02/2004 | US6699997 Carvedilol |
| 03/02/2004 | US6699994 Biaryl compounds as serine protease inhibitors |
| 03/02/2004 | US6699899 Substituted acylhydroxamic acids and method of reducing TNFα levels |
| 03/02/2004 | US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims |
| 03/02/2004 | US6699891 Npyy5 antagonists |
| 03/02/2004 | US6699881 Thiol compounds, their production and use |
| 03/02/2004 | US6699864 Substituted phenyl-piperazine derivatives, their preparation and use |
| 03/02/2004 | US6699863 Regulate, modulate and/or inhibit abnormal cell proliferation. |
| 03/02/2004 | US6699862 Antitumor |
| 03/02/2004 | US6699651 Base precursors for use in a photothermographic element |
| 03/02/2004 | US6699647 Tellurium chemical sensitizers added to the photothermographic emulsion, for example tellurium complexed with four imidazolidin-2-thione groups and two chlorine atoms |
| 03/02/2004 | CA2138289C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/26/2004 | WO2004016619A1 Broadspectrum substituted oxindole sulfonamide hiv protease inhibitors |
| 02/26/2004 | WO2004016596A1 Condensed heterocyclic compounds as pde-iv inhibitors for the treatment of inflammatory and allergic disorders |
| 02/26/2004 | WO2004016576A1 Fused benzene derivative and use |
| 02/26/2004 | WO2004003510A3 Fluorescent dyes, energy transfer couples and methods |
| 02/26/2004 | WO2003059898A3 Eponemycin and epoxomicin analogs and uses thereof |
| 02/26/2004 | WO2003057144A3 Change inhibitors of dipeptidyl peptidase iv |
| 02/26/2004 | WO2003051837A3 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) |
| 02/26/2004 | WO2002066672A3 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 02/26/2004 | US20040039196 (2-Oxindol-3-ylidenyl) acetic acid derivatives and their use as protein kinase inhibitors |
| 02/26/2004 | US20040039064 Treating and/or preventing alzheimer's disease and other neurodegenerative diseases; beta-secretase inhibitors |
| 02/26/2004 | US20040039045 (2-azabicyclo(2.2.1)hept-7yl)methylcarbamate derivatives are useful for treating schizophrenia, Alzheimer's disease, neurodegenerative disorders, Parkinson's disease, Tourette's syndrome, age related memory loss and withdrawal symptoms |
| 02/26/2004 | US20040039034 Hydroxypropyl amides for the treatment of Alzheimer's disease |
| 02/26/2004 | US20040039016 HIV protease inhibitors |
| 02/26/2004 | US20040038973 Treating osteoarthritis or rheumatoid arthritis |
| 02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
| 02/26/2004 | US20040038943 Indole and benzimidazole 15-lipoxygenase inhibitors |
| 02/26/2004 | US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 02/26/2004 | US20040038140 Such as N,N'-bis(3-methoxypropyl)-3,3',4,4'-benzophenone tetracarboxylic diimide; for use in electrophotographic imaging |
| 02/26/2004 | US20040037022 Aminoalcohol derivatives |
| 02/26/2004 | DE10232020A1 Neurorezeptoraktive Heteroarencarboxamide Neuroreceptor Active Heteroarencarboxamide |
| 02/26/2004 | CA2495383A1 Fused benzene derivative and use |
| 02/25/2004 | EP1391456A1 2-iminoimidazole derivative (2) |
| 02/25/2004 | EP1391451A1 2-iminopyrrolidine derivates |
| 02/25/2004 | EP1390348A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | EP1390029A1 Phenylindoles for the treatment of hiv |
| 02/25/2004 | EP1181269B1 Cell proliferation inhibitors |
| 02/25/2004 | EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 02/25/2004 | CN1478080A Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/25/2004 | CN1478075A Chemical process and new intermediates |
| 02/25/2004 | CN1139573C Fused isoindoloness as inhibitors of protein kinase C |
| 02/25/2004 | CN1139572C NMDA (N-methl-D-aspartate) antagonists |
| 02/25/2004 | CN1139570C Inhibition of matrix metalloproteases by acetylene-containing compound |
| 02/24/2004 | US6696573 Synthesis of such as 2-(n-(2-(9h-carbazol-2-yloxy)ethyl))-amino-1-((3 -methylsulfonylamino)phenyl)ethanol with enhanced optical purity |
| 02/24/2004 | US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives |
| 02/24/2004 | US6696482 Formulations for hydrophobic pharmaceutical agents |
| 02/24/2004 | US6696481 Immediate-release tablets; treatment of arterial hypertension and heart failure |
| 02/24/2004 | US6696479 Crystalline forms |
| 02/24/2004 | US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 02/24/2004 | US6696463 3-heteroarylidenyl-2-azaindolinones active as protein tyrosine kinase inhibitors |
| 02/24/2004 | US6696442 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 02/24/2004 | US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example |
| 02/24/2004 | US6696418 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
| 02/24/2004 | US6695969 Displacement chromatography and involves using a displacer for displacing the hmg-coa reductase inhibitor |
| 02/24/2004 | CA2279186C Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 02/19/2004 | WO2004015025A1 Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions |
| 02/19/2004 | WO2004014871A1 Vanilloid receptor ligands and their use in treatments |
| 02/19/2004 | WO2004014863A1 Benzoylpyrazolones substituted by 3-aminocarbonyl |
| 02/19/2004 | WO2004014857A1 Indolenine compound, near infrared absorber, and toner containing the same |
| 02/19/2004 | WO2004014856A1 2,3-dihydro-isoindol-1-ones with mao-b inhibiting activity |
| 02/19/2004 | WO2004014855A1 Processes and polymorphs of diaryl-indolone galr3 antagonists |
| 02/19/2004 | WO2004014854A1 3-imino-2-indolones for the treatment of depression and/or anxiety |
| 02/19/2004 | WO2004014853A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 02/19/2004 | WO2004014851A2 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2004014842A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/19/2004 | WO2004014365A1 Phthalimide derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014364A1 Substituted phenylindoles for the treatment of hiv |
| 02/19/2004 | WO2004014363A1 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonist |
| 02/19/2004 | WO2004014357A2 Therapeutic use of aryl amino acid derivatives |
| 02/19/2004 | WO2004014300A2 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2004014294A2 4,7-disubstituted indoles and methods of making |
| 02/19/2004 | WO2003065989A3 (oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 02/19/2004 | US20040034250 Nitrosylating (with nitrosyl tetrafluoroborate) in presence of base then hydrolyzing to give hydroxy-imino derivative, followed by hydrogenation; for production of benazepril |
| 02/19/2004 | US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin |
| 02/19/2004 | US20040034090 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors |